author-photo

Kathleen Halka

Scott & White Hospital

11

Papers

890

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with High-Risk and Relapsed/Refractory Acute Myeloid Leukemia (AML)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of BP1001 (liposomal Grb2 antisense oligonucleotide) in patients with hematologic malignancies.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

2014 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (776)
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor

2013
Show All
- Source
- Cite
- Save
Citations (0)
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(

2013
Show All
- Source
- Cite
- Save
Citations (3)
Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review

2011
Show All
- Source
- Cite
- Save
Citations (2)
Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.

2011
Show All
- Source
- Cite
- Save
Citations (49)